Figure 4.
Four-year biochemical relapse-free survival in patients with prostate specific-antigen doubling time (PSADT) ≥ 7 months and that in patients with PSADT < 7 months.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.